Resihance 40 mg (Regorafenib) is a drug that has recently been approved by the US Food and Drug Administration to treat chronic and cancer-related diseases. This medication is an oral tablet taken three times a day and is used to treat certain types of colorectal, rectum, and stomach cancers.
Resihance (Regorafenib) works by blocking proteins in cancer cells that are involved in cell growth.
Reviews
There are no reviews yet.